Intego Clinical, a full-service biometrics Clinical Research Organization (CRO) that helps leading life science companies unlock the power of clinical data, has been accepted to provide 3 presentations and papers at this year’s PHUSE US Connect – the clinical data science conference – taking place February 25-28, 2024.
Presentations and papers from Intego Clinical biometrics experts at this year’s clinical data science event include:
- “Navigating the Safe Integration of AI (ChatGPT) into Clinical Trial Programming Workflow,” presented by Senior Statistical Programmer Mykyta Vysotskyi.
- “Risk-Based Monitoring Using AI/ML Detection of Systematic Bias in Clinical Data,” presented by Lead Data Scientist Kostiantyn Drach and CEO Sergey Glushakov in the PHUSE/FDA Innovation Challenge.
- “It is Time to Get Answers: Handling of Questionnaire Data in Respiratory Studies,” presented by Senior Statistical Programmer Valeriia Oreshko.
“It is incredibly satisfying to see the biometrics team have the ability to display our AI, machine learning, and clinical data science knowledge in such a public forum, as we do on a daily basis for a number of the world’s largest pharmaceutical companies,” said Glushakov. “Innovation is in our company’s DNA. It is our mission to leverage data science to spark clinical breakthroughs and we are proud to have the opportunity to showcase these innovations through plenary sessions and the FDA Innovation Challenge.”
